Passa al contenuto
Merck
  • Unambiguous identification and characterization of a long-term human metabolite of dehydrochloromethyltestosterone.

Unambiguous identification and characterization of a long-term human metabolite of dehydrochloromethyltestosterone.

Drug testing and analysis (2018-03-24)
Guro Forsdahl, Thomas Geisendorfer, Lorenz Göschl, Sandra Pfeffer, Peter Gärtner, Mario Thevis, Günter Gmeiner
ABSTRACT

In doping control analysis, the characterization of urinary steroid metabolites is of high interest for a targeted and long-term detection of prohibited anabolic androgenic steroids (AAS). In this work, the structure of a long-term metabolite of dehydrochloromethyltestosterone (DHCMT) was elucidated. Altogether, 8 possible metabolites with a 17α-methyl-17β-hydroxymethyl - structures were synthesized and compared to a major DHCMT long-term metabolite detected in reference urine excretion samples. The confirmed structure of the metabolite was 4α-chloro-18-nor-17β-hydroxymethyl-17α-methyl-5α-androst-13-en-3α-ol.